Showing 2411-2420 of 2494 results for "".
- Canon Xephilio OCT-A1 Device Receives FDA 510(k) Clearancehttps://modernod.com/news/canon-xephilio-oct-a1-device-receives-fda-510k-clearance/2476889/Expanding the company’s lineup of eye care product offerings, Canon USA announced the new intuitive Xephilio OCT-A1 device. This device features automated acquisition functionality, which makes it easy to use, allowing healthcare professionals to obtain high
- MST Innovations Introduces the Scleral IOL Fixation Solutions Packhttps://modernod.com/news/mst-innovations-introduces-the-scleral-iol-fixation-solutions-pack/2476857/MicroSurgical Technology has introduced the Scleral IOL Fixation Solutions Pack, which is designed to streamline the double-needle scleral IOL fixation technique with several unique new instruments that are conveniently packaged to support the procedure end-to-end. The comprehensive offeri
- Lenstec Completes FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-fda-trial-for-sbl-3-iol/2476837/Lenstec announced that it has completed its FDA trial for the SBL-3 IOL (Segmented Bifocal Lens), an asymmetric multifocal refractive IOL designed to provide patients with superior near, intermediate, and distance vision. It also offers improved contrast sensitivity and minimizes halos and glare
- Now Optics Names Two Women to its Executive Leadership Teamhttps://modernod.com/news/now-optics-names-two-women-to-its-executive-leadership-team/2476834/Now Optics recently named two women to its leadership team. Former CVS Health’s Morgan Diaz joined Now Optics as senior vice president of operations and business development, and Lukana Justin previously from Office Depot Inc. is the new, senior vice president of marketing. They join Tara Pellegr
- Clearside Biomedical Provides New Drug Application Update for Xiperehttps://modernod.com/news/clearside-biomedical-provides-new-drug-application-update-for-xipere/2476815/Clearside Biomedical announced an update regarding the company’s new drug application (NDA) for Xipere (triamcinolone acetonide suprachoroidal injectable suspension) with the FDA. In a meeting this week, the FDA’s Office of Pharmaceutical Quality (OPQ) reque
- Maui Jim and VSP Global Expand Relationship to Include Maui Jim Inside the VSP Formularyhttps://modernod.com/news/maui-jim-and-vsp-global-expand-relationship-to-include-maui-jim-inside-the-vsp-formulary/2479547/Maui Jim, the sunglass and eyewear supplier, announced “a significant step forward in its ongoing relationship with VSP Global,” reporting that Maui Jim will officially be available within the VSP formulary and will be included in the VSP contract lab network, according to a VisionMon
- Cloud-Based Telemedicine Platform May Cut Unnecessary Ophthalmology Referralshttps://modernod.com/news/cloud-based-telemedicine-platform-may-cut-unnecessary-ophthalmology-referrals/2476804/Implementation of a cloud-based telemedicine platform can reduce unnecessary ophthalmology referrals by more than half, according to a retrospective study from the UK, as reported by Reuters Health. “Telemedicine offers the o
- Ash Attia Becomes News CEO of Bionic Vision Technologieshttps://modernod.com/news/ash-attia-becomes-news-ceo-of-bionic-vision-technologies/2476797/Bionic Vision Technologies (BVT) has announced that Ash Attia has been named Chief Executive Officer (CEO), effective July 22. This appointment rounds comes shortly after the appointment of Brian Gordon as Chie
- Glaukos Announces Agreement to Buy Avedro in All-Stock Dealhttps://modernod.com/news/glaukos-announces-agreement-to-buy-avedro-in-all-stock-deal/2479551/In a move to diversify its offerings and expand its corneal health franchise, Glaukos agreed to acquire cross-linking company Avedro in an all-stock transaction.
- Hillrom Introduces Next-Generation Technology In Fight Against Diabetic Retinopathyhttps://modernod.com/news/hillrom-introduces-next-generation-technology-in-fight-against-diabetic-retinopathy/2476777/Hillrom announced its latest innovation in vision screening and diagnostics with the introduction of the Welch Allyn RetinaVue 700 Imager handheld retinal camera, which enables remote ophthalmologists to diagnose diabetic retinopathy during routine primary care office visits. “Our n